Donica, H. et al. 2012. The importance of the chromogranin concentration in evaluation of monitoring of treatment effectiveness with the somatostatin analogues in patients with neuroendocrine tumors. Current Issues in Pharmacy and Medical Sciences. 24, 4 (Oct. 2012), 159–165. DOI:https://doi.org/10.12923/.